These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 1357705)
1. Morphine withdrawal aggression: modification with D1 and D2 receptor agonists. Tidey JW; Miczek KA Psychopharmacology (Berl); 1992; 108(1-2):177-84. PubMed ID: 1357705 [TBL] [Abstract][Full Text] [Related]
2. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum. Hu XT; Brooderson RJ; White FJ Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592 [TBL] [Abstract][Full Text] [Related]
3. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia. Lublin H; Gerlach J; Peacock L Clin Neuropharmacol; 1992 Dec; 15(6):448-58. PubMed ID: 1362136 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Engber TM; Marin C; Susel Z; Chase TN Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole. Zhou LW; Qin ZH; Weiss B Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250 [TBL] [Abstract][Full Text] [Related]
6. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists. Wang HY; Zhou LW; Friedman E; Weiss B Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235 [TBL] [Abstract][Full Text] [Related]
7. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia. Mittleman G; LeDuc PA; Whishaw IQ Behav Brain Res; 1993 Jun; 55(2):253-67. PubMed ID: 8102851 [TBL] [Abstract][Full Text] [Related]
8. Co-activation of D1- and D2-like receptors is unnecessary for stimulated motor behavior in rats depleted of dopamine during development. Byrnes EM; Abrams D; Bruno JP Behav Brain Res; 1994 Apr; 61(2):205-14. PubMed ID: 7913605 [TBL] [Abstract][Full Text] [Related]
9. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981 [TBL] [Abstract][Full Text] [Related]
10. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Subramaniam S; Lucki I; McGonigle P Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781 [TBL] [Abstract][Full Text] [Related]
11. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393. Williams JE; Woolverton WL Pharmacol Biochem Behav; 1990 Oct; 37(2):289-93. PubMed ID: 1981936 [TBL] [Abstract][Full Text] [Related]
12. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]
13. The effects of morphine on memory consolidation in mice involve both D1 and D2 dopamine receptors. Castellano C; Cestari V; Cabib S; Puglisi-Allegra S Behav Neural Biol; 1994 Mar; 61(2):156-61. PubMed ID: 7911301 [TBL] [Abstract][Full Text] [Related]
14. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats. Neisewander JL; Lucki I; McGonigle P Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600 [TBL] [Abstract][Full Text] [Related]
15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
16. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. LaHoste GJ; Yu J; Marshall JF Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797 [TBL] [Abstract][Full Text] [Related]
17. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro. Momiyama T; Todo N; Sasa M Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652 [TBL] [Abstract][Full Text] [Related]
18. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors. Abraini JH; Fechtali T; Rostain JC Neuroscience; 1992 Sep; 50(2):395-402. PubMed ID: 1359460 [TBL] [Abstract][Full Text] [Related]
19. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Borowsky B; Kuhn CM Neuropharmacology; 1992 Jul; 31(7):671-8. PubMed ID: 1328919 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area. Momiyama T; Sasa M; Takaori S Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]